322 related articles for article (PubMed ID: 20534141)
1. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
[TBL] [Abstract][Full Text] [Related]
2. Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer.
Molano M; Moreno-Acosta P; Morales N; Burgos M; Buitrago L; Gamboa O; Alvarez R; Garland SM; Tabrizi SN; Steenbergen RD; Mejía JC
Cancer Genomics Proteomics; 2016 11-12; 13(6):483-491. PubMed ID: 27807071
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.
Oikonomou P; Messinis I; Tsezou A
Exp Biol Med (Maywood); 2007 Jul; 232(7):881-6. PubMed ID: 17609503
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.
de Wilde J; Wilting SM; Meijer CJ; van de Wiel MA; Ylstra B; Snijders PJ; Steenbergen RD
Int J Cancer; 2008 Feb; 122(4):877-88. PubMed ID: 17960611
[TBL] [Abstract][Full Text] [Related]
6. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
[TBL] [Abstract][Full Text] [Related]
7. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
Li F; Cui J
Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.
Katzenellenbogen RA; Vliet-Gregg P; Xu M; Galloway DA
J Virol; 2010 Dec; 84(24):12934-44. PubMed ID: 20943973
[TBL] [Abstract][Full Text] [Related]
9. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
10. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.
Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M
PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
Kailash U; Soundararajan CC; Lakshmy R; Arora R; Vivekanandhan S; Das BC
Br J Cancer; 2006 Nov; 95(9):1250-7. PubMed ID: 17060942
[TBL] [Abstract][Full Text] [Related]
12. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.
Liu X; Roberts J; Dakic A; Zhang Y; Schlegel R
Virology; 2008 Jun; 375(2):611-23. PubMed ID: 18367227
[TBL] [Abstract][Full Text] [Related]
13. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
14. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.
Steenbergen RD; Kramer D; Meijer CJ; Walboomers JM; Trott DA; Cuthbert AP; Newbold RF; Overkamp WJ; Zdzienicka MZ; Snijders PJ
J Natl Cancer Inst; 2001 Jun; 93(11):865-72. PubMed ID: 11390536
[TBL] [Abstract][Full Text] [Related]
15. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.
Takakura M; Kyo S; Kanaya T; Hirano H; Takeda J; Yutsudo M; Inoue M
Cancer Res; 1999 Feb; 59(3):551-7. PubMed ID: 9973199
[TBL] [Abstract][Full Text] [Related]
16. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
[TBL] [Abstract][Full Text] [Related]
17. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Guilleret I; Yan P; Grange F; Braunschweig R; Bosman FT; Benhattar J
Int J Cancer; 2002 Oct; 101(4):335-41. PubMed ID: 12209957
[TBL] [Abstract][Full Text] [Related]
19. Quantitative determination of human telomerase reverse transcriptase messenger RNA expression in premalignant cervical lesions and correlation with human papillomavirus load.
Oikonomou P; Mademtzis I; Messinis I; Tsezou A
Hum Pathol; 2006 Feb; 37(2):135-42. PubMed ID: 16426912
[TBL] [Abstract][Full Text] [Related]
20. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
